[HTML][HTML] Emerging therapies against infections with Pseudomonas aeruginosa
B Tümmler - F1000Research, 2019 - ncbi.nlm.nih.gov
Infections with Pseudomonas aeruginosa have been marked with the highest priority for
surveillance and epidemiological research on the basis of parameters such as incidence …
surveillance and epidemiological research on the basis of parameters such as incidence …
Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa
N Araya, MA Leiva-Soto, MV Bruna… - Frontiers in …, 2022 - frontiersin.org
Buddleja globosa Hope (BG) extracts are traditionally used to treat skin and gastric ulcers
due to their healing properties. Non-aqueous solvents such as ethanol and DMSO are …
due to their healing properties. Non-aqueous solvents such as ethanol and DMSO are …
Targeting biofilms in chronic respiratory infections using drug delivery systems
Bacterial biofilm infections caused by Pseudomonas aeruginosa is one of the main reasons
contributing to the morbidity and mortality in patients with lung infections such as cystic …
contributing to the morbidity and mortality in patients with lung infections such as cystic …
Overcoming pathogenic biofilm recalcitrance with magnetic mitigation therapies
LA Heersema - 2019 - repositories.lib.utexas.edu
Pathogenic biofilms are associated with the chronicity of infectious diseases and are difficult
to treat using current therapies. Biofilm recalcitrance enables antibiotic resistance up to …
to treat using current therapies. Biofilm recalcitrance enables antibiotic resistance up to …